Format
Sort by

Send to

Choose Destination

Search results

Items: 15

1.

Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.

Gao Y, Ren H, Meng F, Li J, Cheung E, Li H, Zhao J, Liu H, Liu Z, Zhang M.

PLoS One. 2016 Apr 28;11(4):e0154419. doi: 10.1371/journal.pone.0154419. eCollection 2016.

2.

The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis.

Greenaway C, Thu Ma A, Kloda LA, Klein M, Cnossen S, Schwarzer G, Shrier I.

PLoS One. 2015 Nov 11;10(11):e0141715. doi: 10.1371/journal.pone.0141715. eCollection 2015. Review. Erratum in: PLoS One. 2015;10(12):e0144567.

3.
4.

Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts.

Yehia BR, Herati RS, Fleishman JA, Gallant JE, Agwu AL, Berry SA, Korthuis PT, Moore RD, Metlay JP, Gebo KA; HIV Research Network.

PLoS One. 2014 Jul 17;9(7):e102766. doi: 10.1371/journal.pone.0102766. eCollection 2014.

5.

The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.

Yehia BR, Schranz AJ, Umscheid CA, Lo Re V 3rd.

PLoS One. 2014 Jul 2;9(7):e101554. doi: 10.1371/journal.pone.0101554. eCollection 2014. Review.

6.

Hepatitis C virus infection causes iron deficiency in Huh7.5.1 cells.

Fillebeen C, Pantopoulos K.

PLoS One. 2013 Dec 13;8(12):e83307. doi: 10.1371/journal.pone.0083307. eCollection 2013.

7.

Clinical outcomes of hepatitis C treated with pegylated interferon and ribavirin via telemedicine consultation in Northern California.

Rossaro L, Torruellas C, Dhaliwal S, Botros J, Clark G, Li CS, Minoletti MM.

Dig Dis Sci. 2013 Dec;58(12):3620-5. doi: 10.1007/s10620-013-2810-y. Epub 2013 Oct 24.

8.

Synthetic antigens representing the antigenic variation of human hepatitis C virus.

Kang KH, Yamamura Y, Carlos MP, Karvelas N, Kim IS, Sunkara D, Rivera R, Gardner MB, Anderson DE, Diaz-Mitoma F, Torres J, Marquez JP.

Viral Immunol. 2010 Oct;23(5):497-508. doi: 10.1089/vim.2010.0043.

9.

The evaluation of patients with hepatitis C living in rural California via telemedicine.

Rossaro L, Aoki C, Yuk J, Prosser C, Goforth J, Martinez F.

Telemed J E Health. 2008 Dec;14(10):1127-9. doi: 10.1089/tmj.2008.0029.

10.

Liver transplant and hepatitis C in methadone maintenance therapy: a case report.

Hancock MM, Prosser CC, Ransibrahmanakul K, Lester L, Craemer E, Bourgeois JA, Rossaro L.

Subst Abuse Treat Prev Policy. 2007 Feb 1;2:5.

11.

Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage.

Lin R, Lacoste J, Nakhaei P, Sun Q, Yang L, Paz S, Wilkinson P, Julkunen I, Vitour D, Meurs E, Hiscott J.

J Virol. 2006 Jun;80(12):6072-83.

12.

PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone.

Rivas-Estilla AM, Svitkin Y, Lopez Lastra M, Hatzoglou M, Sherker A, Koromilas AE.

J Virol. 2002 Nov;76(21):10637-53.

13.
14.

Seronegative hepatitis C virus liver failure following transplantation of a cadaveric heart.

Hayashi PH, Fernando L, Schuch DR, Koldinger R, Kelly PB, Ingram M, DeFelice R, Marriott SE, Holland PV, Zeldis JB.

West J Med. 1994 Apr;160(4):368-71. No abstract available.

15.

Hepatitis C virus in blood samples from volunteer donors.

Zhang HY, Kuramoto IK, Mamish D, Sazama K, Holland PV, Zeldis JB.

J Clin Microbiol. 1993 Mar;31(3):606-9.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk